AU2001266347A1 - Enteric preparations containing physiologically active peptides - Google Patents

Enteric preparations containing physiologically active peptides

Info

Publication number: AU2001266347A1
Authority: AU; Australia
Prior art keywords: physiologically active; preparations containing; active peptides; containing physiologically; enteric preparations
Prior art date: 2000-07-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001266347A

Inventor

Katsuji Sugita

Takayoshi Yoshikawa

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Shionogi and Co Ltd

Original Assignee

Shionogi and Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-11

Filing date

2001-06-28

Publication date

2002-01-21

2001-06-28 Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd

2002-01-21 Publication of AU2001266347A1 publication Critical patent/AU2001266347A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/066—TRH, thyroliberin, thyrotropin releasing hormone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2001266347A 2000-07-11 2001-06-28 Enteric preparations containing physiologically active peptides Abandoned AU2001266347A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000209923		2000-07-11
JP2000-209923		2000-07-11
PCT/JP2001/005543 WO2002004016A1 (en)	2000-07-11	2001-06-28	Enteric preparations containing physiologically active peptides

Publications (1)

Publication Number	Publication Date
AU2001266347A1 true AU2001266347A1 (en)	2002-01-21

Family

ID=18706267

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001266347A Abandoned AU2001266347A1 (en)	2000-07-11	2001-06-28	Enteric preparations containing physiologically active peptides

Country Status (5)

Country	Link
US (1)	US20030175350A1 (en)
EP (1)	EP1300155A1 (en)
JP (1)	JP4812225B2 (en)
AU (1)	AU2001266347A1 (en)
WO (1)	WO2002004016A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004010516A1 (en) *	2004-03-04	2005-09-22	Bayer Technology Services Gmbh	Improved process for the timely dosing of drugs
ES2727452T3 (en) *	2004-09-09	2019-10-16	Shionogi & Co	Pharmaceutical composition to treat ataxia, multisystemic atrophy or balance disorders
TWI350754B (en)	2004-09-09	2011-10-21	Shionogi & Co	A pharmaceutical composition for treating spinocerebellar ataxia
EP1901763A4 (en) *	2005-03-09	2009-10-21	Roger Williams Hospital	ANALOGUE OF THYROTROPIN RELEASING HORMONE AND METHOD OF USE
MX2007011453A (en)	2005-04-22	2008-02-12	Alantos Pharmaceuticals Holding Inc	Dipeptidyl peptidase-iv inhibitors.
JP5836980B2 (en)	2013-01-11	2015-12-24	信越化学工業株式会社	Drug-containing particles, solid preparation and method for producing drug-containing particles
WO2017099952A1 (en) *	2015-12-08	2017-06-15	Dow Global Technologies Llc	Compositions comprising cellulose ethers and water-soluble esterified cellulose ethers
JP7640815B2 (en)	2022-07-20	2025-03-05	塩野義製薬株式会社	Preparations containing biologically active peptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3737549A (en) *	1972-03-20	1973-06-05	Abbott Lab	Method of treating depression
HU180926B (en) *	1979-06-28	1983-05-30	Richter Gedeon Vegyeszet	Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
JPS57171428A (en) *	1981-04-13	1982-10-22	Sankyo Co Ltd	Preparation of coated solid preparation
US4525339A (en) *	1982-10-15	1985-06-25	Hoffmann-La Roche Inc.	Enteric coated oral dosage form
CA1256650A (en) *	1983-03-25	1989-06-27	Toshinari Tamura	Process of producing 2-azetidinone-4-substituted compounds, and medicaments containing the compounds
AU713133B2 (en) *	1996-08-28	1999-11-25	Shionogi & Co., Ltd.	Novel peptide derivatives having thiazolyl-alanine residue
JPH10130171A (en) *	1996-09-04	1998-05-19	Dot:Kk	Pharmaceutical composition for oral administration
CN1228708A (en) *	1996-09-04	1999-09-15	有限会社多特	Peptide-containing drug compositions for oral administration
US6319902B1 (en) *	1997-08-22	2001-11-20	Shionogi & Co., Ltd.	Peptide derivatives having thiazolyl-alanine residue

2001
- 2001-06-28 US US10/332,490 patent/US20030175350A1/en not_active Abandoned
- 2001-06-28 EP EP01943852A patent/EP1300155A1/en not_active Withdrawn
- 2001-06-28 WO PCT/JP2001/005543 patent/WO2002004016A1/en not_active Ceased
- 2001-06-28 JP JP2002508470A patent/JP4812225B2/en not_active Expired - Fee Related
- 2001-06-28 AU AU2001266347A patent/AU2001266347A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1300155A1 (en)	2003-04-09
JP4812225B2 (en)	2011-11-09
WO2002004016A1 (en)	2002-01-17
US20030175350A1 (en)	2003-09-18

Publication	Publication Date	Title
AU2001276737A1 (en)	2002-02-18	Protein injection preparations
CZ20011229A3 (en)	2001-11-14	Ophthalmological preparations
AU2001236005A1 (en)	2001-09-12	Preparations stabilized over long time
AU2001234114A1 (en)	2001-09-03	Drugs containing combined active ingredients
AU2575000A (en)	2000-09-04	Collagen-binding physiologically active polypeptide
AU2001284444A1 (en)	2002-06-13	Preparations for oral administration
AU2001282607A1 (en)	2002-06-06	Solution preparations stabilized over long time
AU2001248215A1 (en)	2001-11-26	Cosmetically active composition
AU5469801A (en)	2001-10-08	Pro-liposomal encapsulated preparations (iv)
AU1608201A (en)	2001-05-30	Human zven proteins
AU2001292574A1 (en)	2002-03-22	Human phermone polypeptide
AU2001242479A1 (en)	2001-10-15	Proliposomal encapsulated preparations
AU2001266347A1 (en)	2002-01-21	Enteric preparations containing physiologically active peptides
IL147731A0 (en)	2002-08-14	Peptide pharmaceutical formulations
AU2231601A (en)	2001-07-09	Vancomycin preparations
AU2001277696A1 (en)	2002-02-13	Novel physiologically active peptide and use thereof
AU6179600A (en)	2001-04-10	Peptides and pharmaceutical compositions comprising same
AU3473800A (en)	2000-08-18	Conotoxin peptides
AU2001296389A1 (en)	2002-04-08	Stable peptide formulations
AU1800100A (en)	2000-07-31	Medicinal preparations
AU2001282521A1 (en)	2002-06-06	OCT preparations
AU2002230129A1 (en)	2002-08-19	Novel physiologically active peptide and use thereof
AU3930399A (en)	1999-12-06	Cyclosporin preparations
AU8252101A (en)	2002-03-13	Oct preparations
AU1179600A (en)	2000-06-05	Physiologically active peptides